|
UBE2H expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.976600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.289800E-01 |
| Normal-vs-Stage2 |
2.274200E-01 |
| Normal-vs-Stage3 |
4.253400E-01 |
| Normal-vs-Stage4 |
4.590800E-01 |
| Stage1-vs-Stage2 |
1.781760E-01 |
| Stage1-vs-Stage3 |
3.053200E-01 |
| Stage1-vs-Stage4 |
2.441000E-01 |
| Stage2-vs-Stage3 |
5.049600E-01 |
| Stage2-vs-Stage4 |
7.310400E-01 |
| Stage3-vs-Stage4 |
8.536800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.576000E-01 |
| Normal-vs-AfricanAmerican |
8.215200E-01 |
| Normal-vs-Asian |
9.835800E-01 |
| Caucasian-vs-AfricanAmerican |
6.476800E-01 |
| Caucasian-vs-Asian |
7.882400E-01 |
| AfricanAmerican-vs-Asian |
9.279200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.851400E-01 |
| Normal-vs-Female |
3.881300E-03 |
| Male-vs-Female |
2.536900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.520200E-01 |
| Normal-vs-Extreme_Weight |
2.125000E-01 |
| Normal-vs-Obese |
8.325600E-02 |
| Normal-vs-Extreme_Obese |
7.670600E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.223200E-01 |
| Normal_Weight-vs-Obese |
2.544000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.445600E-01 |
| Extreme_Weight-vs-Obese |
1.910130E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.008600E-01 |
| Obese-vs-Extreme_Obese |
6.388000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.246770E-01 |
| Normal-vs-Age(41-60Yrs) |
8.289700E-02 |
| Normal-vs-Age(61-80Yrs) |
9.489000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.175400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.064400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.832500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.220100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.742590E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.395960E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.929000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.022200E-01 |
| Normal-VS-Type2 PRCC |
6.024000E-01 |
| Normal-VS-KIRP CIMP |
1.791880E-02 |
| Normal-VS-Unclassified PRCC |
2.663400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.413200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.972300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
5.936200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.396340E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.654580E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.736100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.143700E-02 |
| Normal-vs-N1 |
3.942300E-02 |
| Normal-vs-N2 |
4.833600E-01 |
| N0-vs-N1 |
6.202500E-03 |
| N0-vs-N2 |
3.540600E-01 |
| N1-vs-N2 |
9.214400E-01 |
|
|
